Title : Current status of immunotherapy.

Pub. Date : 2016 Mar

PMID : 26819277






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Anti-CTLA-4 monoclonal antibody, ipilimumab, is the first-approved immune checkpoint inhibitor and has shown durable objective responses for advanced melanoma beyond the effect of dacarbazine. Dacarbazine cytotoxic T-lymphocyte associated protein 4 Homo sapiens